The short-term outlook is bullish for Glenmark Pharmaceuticals.The stock has formed a good base above ₹2,150. The recent rise is also occurring on strong trendline support. Both these factors indicate that the corrective fall has ended and a new leg of the upmove has begun.A cluster of supports is there in the ₹2,220-₹2,180 region. Fresh buyers can enter the market around this support zone to limit downside. Glenmark Pharmaceuticals’ share price can rise to ₹2,500 in the coming week.Traders can buy Glenmark Pharmaceuticals shares at ₹2,270 now. Accumulate on dips at ₹2,240. Keep the stop-loss at ₹2,130. Trail the stop-loss up to ₹2,295 as soon as the stock goes up to ₹2,330. Revise the stop-loss higher to ₹2,360 and ₹2,420 when the price touches ₹2,410 and ₹2,440, respectively. Exit the long positions at ₹2,480.Video Credit: Businessline(Note: The recommendations are based on technical analysis. There is risk of loss in trading.)Published on July 7, 2026